HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effects of sulpiride on persistent neuroleptic-induced dyskinesia in monkeys.

Abstract
Five Cebus apella monkeys with persistent neuroleptic-induced dyskinesia were given a single dose of sulpiride (20 mg/kg i.m.). The dyskinesia was reduced in all five although four developed attacks of acute dystonia which had to be reversed by anticholinergic medication in three animals. In one monkey the administration of classic neuroleptics had earlier been shown to induce a typical sequence of events. First there was a similar reduction of dyskinesia as seen in the other monkeys, 1-2 days later there was noticed a rebound deterioration lasting for several days. Metoclopramide 0.5 mg/kg, caused such a rebound effect (for 2 days), whereas sulpiride did not.
AuthorsJ E Häggström
JournalActa psychiatrica Scandinavica. Supplementum (Acta Psychiatr Scand Suppl) Vol. 311 Pg. 103-8 ( 1984) ISSN: 0065-1591 [Print] Denmark
PMID6142586 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antipsychotic Agents
  • Sulpiride
  • Metoclopramide
Topics
  • Animals
  • Antipsychotic Agents (adverse effects)
  • Cebus
  • Dyskinesia, Drug-Induced (drug therapy, etiology)
  • Dystonia (chemically induced)
  • Metoclopramide (pharmacology)
  • Sulpiride (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: